Polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Control group: oral rehydration salts (ORS, Poursina, Tehran, Iran) two times daily. Intervention 2: Intervention group 1: received Met (Glucophage, Merck, West Drayton, UK
500 mg two times daily). Intervention 3: Intervention group2: received Sita (Januvia, Merck,West Drayton, UK. 50 mg two times daily). Intervention 4: Intervention group3: which received Sitaformin (Ja
Sponsors
Arak university
Infertility and Reproductive Health Research Center Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
25 Years to 35 Years
Inclusion criteria
Inclusion criteria: infertile Patients with polycystic Ovary Syndrome age range of 25 to 35 years
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| No. of Oocyte retrieved. Timepoint: once, in day of puncture. Method of measurement: Oocyte retrieval was performed by ultrasound-guided transvaginal aspiration using a single-lumen needle. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDelbar Daneshjou
Arak niversity
Outcome results
None listed